Your browser doesn't support javascript.
loading
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano, J Michael; Brotons, Carlos; Coppolecchia, Rosa; Cricelli, Claudio; Darius, Harald; Gorelick, Philip B; Howard, George; Pearson, Thomas A; Rothwell, Peter M; Ruilope, Luis Miguel; Tendera, Michal; Tognoni, Gianni.
Afiliação
  • Gaziano JM; Brigham and Women's Hospital, Department of Medicine, Division of Aging, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; VA Boston Healthcare System, Boston, MA, USA. Electronic address: jmgaziano@partners.org.
  • Brotons C; Sardenya Primary Health Care Center, EAP Sardenya-Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Coppolecchia R; Bayer HealthCare LLC, Whippany, NJ, USA.
  • Cricelli C; Società Italiana di Medicina Generale, Florence, Italy.
  • Darius H; Department of Cardiology, Angiology, Nephrology and Intensive Care Medicine, Vivantes Neukoelln Medical Center, Berlin, Germany.
  • Gorelick PB; Department of Translational Science & Molecular Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI, USA; Vascular Neurology Program, Mercy Health Hauenstein Neurosciences, Grand Rapids, Michigan Grand Rapids, MI, USA.
  • Howard G; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Pearson TA; Department of Epidemiology and Medicine, University of Florida Health Science Center, Gainsville, FL, USA.
  • Rothwell PM; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Ruilope LM; Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain.
  • Tendera M; Department of Cardiology and Structural Heart Disease, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
  • Tognoni G; IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Department of Cardiovascular Research, IRCSS, Milan, Italy.
Lancet ; 392(10152): 1036-1046, 2018 09 22.
Article em En | MEDLINE | ID: mdl-30158069
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Acidente Vascular Cerebral / Infarto do Miocárdio Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores da Agregação Plaquetária / Aspirina / Acidente Vascular Cerebral / Infarto do Miocárdio Idioma: En Ano de publicação: 2018 Tipo de documento: Article